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The adaptor molecules LAT and SLP-76 
are speciﬁcally targeted by 
 
Yersinia
 
 to inhibit 
T cell activation
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T cell responses are critical to the survival of 
 
Yersinia
 
-infected animals. 
 
Yersinia
 
 have the 
ability to directly suppress T lymphocyte activation through the virulence factor YopH, a 
tyrosine phosphatase. Using single cell video microscopy and FACS analysis, here we show 
that even an average of one 
 
Yersinia
 
 per T cell is sufficient to inhibit or alter T cell 
responses. This efficient inhibition is traced to specific targeting by YopH of the adaptor 
proteins, linker for activation of T cells (LAT) and SH2-domain–containing leukocyte protein 
of 76 kD (SLP-76), which are crucial for T cell antigen receptor (TCR) signaling. A 
catalytically inactive YopH translocated via the type III secretory pathway from the bacteria 
into T cells primarily binds to LAT and SLP-76. Furthermore, among the proteins of the TCR 
signaling pathway, the tyrosine phosphorylation levels of LAT and SLP-76 are the most 
affected in T cells exposed to low numbers of 
 
Yersinia pseudotuberculosis
 
. This is the first 
example showing that a pathogen targets these adaptor proteins in the TCR signaling 
pathway, suggesting a novel mechanism by which pathogens may efficiently alter T cell–
mediated immune responses.
 
The success of a pathogen in establishing an
infection is dependent on its ability to avoid or
resist host defense mechanisms. Although
there is ample information on the mechanisms
used by pathogenic bacteria to subvert the in-
nate immune defense system, very little is
known about how they affect the adaptive
immune response (for review see reference 1).
Yet, it is clear that the T cell response remains
essential for the clearance of bacterial patho-
gens, including the pathogenic members of the
genus 
 
Yersinia
 
 (2, 3). The genus 
 
Yersinia
 
 in-
cludes 
 
Yersinia pestis
 
, the causative agent of
plague, as well as 
 
Yersinia pseudotuberculosis
 
 and
 
Yersinia enterocolitica
 
. The latter two cause gas-
troenteritis and lymphadenitis and, in suscepti-
ble individuals, the infections have also been
associated with the development of reactive
arthritis (4).
 
Yersinia
 
’s virulence strategy is to modify
host cell functions by injecting several effector
proteins (the 
 
Yersinia
 
 outermembrane proteins,
Yops) by a type III secretory pathway into the
host cell upon contact (5). Studies of the in
vitro effects of the Yops on macrophages and
epithelial cell lines have been extensive (for re-
views see references 5, 6). During the course of
infection, 
 
Yersinia
 
 are also likely to encounter
lymphocytes as the bacteria colonize and multi-
ply extracellularly in the Peyer’s patches, lymph
nodes, and subsequently in the spleen and liver.
T cells as well as macrophages are present in
 
Yersinia
 
-induced lesions in spleen and liver (2).
We found that T cells transiently exposed to
 
Yersinia
 
 are inhibited in their ability to be acti-
vated through the TCR and, thus, cannot
mount subsequent effector functions (7). This
is one of the first examples of a bacterial patho-
gen that directly inhibits T cell activation.
The virulence factor YopH, a potent phos-
phatase (8–10), was primarily responsible for
this inhibitory effect (7). Surprisingly, YopE,
YopT, and YpkA that are known to disrupt
actin filaments leading to alterations in the cy-
toskeleton of both phagocytes and epithelial
cells (5, 6) have no effects on T cells despite
the fact that a redistribution and reorientation
of the cytoskeleton occurs during lymphocyte
activation. Furthermore, although the viru-
lence factor YopJ was found to induce apoptosis
in macrophages in vivo (11) and to suppress
TNF-
 
 
 
 and IL-8 production in macrophages
in vitro (5, 6), it has no effect on T cells or
TCR-mediated cytokine secretion. Thus, it
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appears that T lymphocyte functions are specifically targeted
by YopH.
YopH was shown in in vitro assays to block the oxida-
tive burst of macrophages (12), to inhibit calcium signaling
in neutrophils (13), to induce disassembly of focal adhesions
in epithelial cells (14, 15), and to inhibit phagocytosis (16).
These studies and our own previous investigation were all
performed with a rather high multiplicity of infection (MOI)
of 
 
 
 
50. Yet, in vivo the bacteria to host cell ratio must be
low, at least at the time of initial infection. Therefore, we set
out to determine the efficacy and mechanism of YopH’s in-
hibition of T cell activation.
Here, we report that YopH alters T cell function even at
a level of just one bacterium per T cell. Consistent with such
high efficiency, we show that the adaptor molecules linker
for activation of T cells (LAT) and SH2-domain–containing
leukocyte protein of 76 kD (SLP-76) that are phosphorylated
in response to TCR stimulation and are essential for T cell
activation are primary targets of YopH. We find that al-
though YopH has a broad targeting capability, it is quite spe-
cific in an infection where the bacteria/target cell ratio is low.
 
RESULTS
 
Yersinia
 
 inhibit T cell responses efficiently
 
To determine the efficacy of YopH’s inhibition of TCR-medi-
ated activation, we analyzed the calcium flux of 
 
Y. pseudotuber-
culosis
 
–exposed T cells as well as the recruitment of phospho-
inositide 3–kinase (PI3K) to the immunological synapse, which
both are important early events in T cell signaling (17–21).
T cell blasts prepared from 5C.C7 
 
  
 
 TCR (specific for
moth cytochrome 
 
c
 
 [MCC] peptide/I-E
 
k
 
) transgenic mice
(22) were exposed to wild-type 
 
Y. pseudotuberculosis
 
 at MOIs
of 1, 2, 5, 10, 20, and 50 for 1 h and concurrently loaded
with the calcium-sensitive dye indo-1 for 30 min. Their abil-
ity to flux calcium in response to CD3
 
 
 
 cross-linking was an-
alyzed by flow cytometry. Ratiometric analysis showed that
the calcium flux of a T cell population exposed to an MOI of
1 was substantially reduced (Fig. 1 A). Incubations with
higher MOIs resulted in a delayed response and a further re-
duction of the intracellular calcium flux levels. Consistent
with our previous finding that YopH is the primary virulence
factor affecting T cell responses (7), we found no inhibition
of calcium flux when T cells were exposed to a 
 
Yersinia
 
 mu-
tant expressing a catalytically inactive YopH, even at an MOI
of 50 (Fig. 1 A). The catalytically inactive YopH stably traps
its targets and thereby likely impairs downstream events.
However, because only a limited mount of YopH is translo-
cated into the host cell even at an MOI of 50, a large number
of phosphorylated signaling proteins is not bound to the sub-
strate trap (unpublished data).
Analysis of calcium levels in individual cells at the peak of
calcium flux (Fig. 1 A, asterisks) showed that both the num-
ber of cells fluxing calcium and the magnitude of the calcium
flux are reduced in T cell populations exposed to 
 
Y. pseudotu-
berculosis
 
 (Fig. 1 B). The dose response curve fits the model of
a Gaussian distribution of the number of bacteria encounter-
ing the T cells where one bacterium per T cell is sufficient to
inhibit the T cell response. Similar results were obtained us-
ing the human Jurkat T cell line (unpublished data).
To evaluate the response of individual cells, the calcium
flux of fura-2 (a calcium-sensitive dye) loaded 5C.C7 T cell
blasts exposed to 
 
Yersinia
 
 at different MOIs and stimulated
by murine CH27 B cells presenting the MCC peptide was
analyzed using video fluorescence microscopy (Fig. 2). As
seen before (Fig. 1), with increasing MOI, an increasing
percentage of the cells could no longer flux calcium. Inter-
estingly, a subset of exposed T cells (
 
 
 
10% at an MOI of 1
and 50% at an MOI of 10) exhibited a “sparking” pheno-
type where the initial increase of intracellular calcium was
almost at the level of stimulated unexposed T cells, but was
followed by a rapid decline to the basal level in 
 
 
 
5 min. In
contrast, unexposed T cells (Fig. 2) or T cells incubated with
a mutant strain of 
 
Y. pseudotuberculosis
 
 expressing inactive
YopH (not depicted) maintained their elevated calcium
concentrations for 
 
 
 
10 min.
Figure 1. TCR-stimulated calcium flux in 5C.C7 T cell blasts exposed 
to different MOIs of wild-type Y. pseudotuberculosis. (A) Calcium flux 
of 5C.C7 T cell blasts either unexposed (unexp.) or exposed to wild-type 
Y. pseudotuberculosis at MOIs of 1, 2, 5, 10, 20, and 50 or to yopHC403A-HA 
(YopHC/A) at an MOI of 50, loaded with the calcium-sensitive dye indo-1 
and activated through the TCR by the addition of anti-CD3  at time 0, was 
measured by flow cytometry. The calcium flux kinetics are plotted as the 
median of the intracellular calcium levels in the population measured in 
three independent experiments versus time. (B) Relative number of cells at 
the peak of the population’s calcium flux (as marked by asterisks in A) that 
show no significant calcium flux or intracellular calcium levels of 1.5-fold 
or 2-fold higher than the initial levels. 
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PI3K activity was assayed indirectly by expressing the
pleckstrin homology (PH) domain of AKT (also known as
protein kinase B) fused to the yellow fluorescent protein
(YFP) (PH[AKT]-YFP) in T cells as described by Huppa et
al. (21). The binding of 3
 
 
 
-phosphoinositides (the products
of PI3K) by the PH domain results in an accumulation of
PH(AKT)-YFP at sites of PI3K activity (20, 21). In unex-
posed 5C.C7 T cell blasts expressing PH(AKT)-YFP, anti-
gen stimulation resulted in a rapid and sustained accumula-
tion at the immunological synapse (front-accumulation) of
PH(AKT)-YFP (Fig. 2). In 
 
Y. pseudotuberculosis
 
–exposed T
cell blasts, PH(AKT)-YFP accumulation was affected. T cells
that did not respond to antigen-presenting cells by elevating
their level of intracellular calcium also did not accumulate
PH(AKT)-YFP. Observations that YopH inhibits PI3K-
dependent T cell proliferation and IL-2 production (23) are
consistent with this result. Exposed T cells exhibiting the
sparking calcium flux also showed a transient front-accumu-
lation of PH(AKT)-YFP. These results demonstrate that low
numbers of 
 
Y. pseudotuberculosis
 
 can either abolish or alter T
cell activation. Infection with 
 
Yersinia
 
 strains lacking a cata-
lytically active YopH did not have any inhibitory effect (un-
Figure 2. Antigen-stimulated calcium flux and PI3K accumulation 
in Yersinia-exposed T cells. (A) 5C.C7 T cell blasts expressing PH(AKT)-YFP 
were exposed to wild-type Y. pseudotuberculosis or left unexposed, loaded 
with the calcium sensitive dye fura-2, mixed with MCC peptide presenting 
CH27 cells, and analyzed by video microscopy. The differential interference 
contrast (DIC), the fura-2 ratio in ratio-dependent false color (calcium), 
and a midplane section of the YFP z-stack (PH[AKT]-YFP) are shown over a 
time frame of 6 min and at 10 min after contact. The full antigen-stimulated 
response in calcium flux and PI3K activity was observed in unexposed 
5C.C7 T cell and the sparking response was observed in Y. pseudotuberculosis–
exposed cells. Image quality of the PH(AKT)-YFP accumulation was improved 
by using a blind deconvolution algorithm to remove out-of-focus light 
from the z-stack. (B) Images of 15 cells of each phenotype were analyzed 
using the Metamorph program. Averages of intracellular calcium levels 
and PH(AKT)-YFP front-accumulation were plotted relatively to their cor-
responding base levels (-fold) versus time. Error bars represent standard 
deviation. Data were acquired at intervals of 30 s over a time frame of 
10 min. 
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published data). The simultaneous inhibition of calcium flux
and PI3K activity suggests that YopH targets a common step
in the signaling cascade upstream of PI3K and phospholipase
C-
 
 
 
1, which is essential for the calcium flux. Partial inhibi-
tion of this step may lead to the sparking phenotype.
 
Phosphorylated LAT and SLP-76 in activated T cells are 
primarily targeted by YopH
 
After T cell activation through the TCR, the TCR CD3
 
 
 
chains, antigen receptor-associated tyrosine kinases, such as
Lck and ZAP-70, and adaptor/linker proteins, including
LAT and SLP-76, are phosphorylated immediately. This
precedes all downstream signaling events including calcium
flux and the activation of PI3K. To understand how YopH
inhibits TCR signaling, we followed up on our previous
finding that, in activated Jurkat T cells exposed to 
 
Y. pseudo-
tuberculosis
 
 at an MOI of 50, most of the TCR signaling–asso-
ciated molecules were either not phosphorylated, or hypo-
phosphorylated (7). To test whether YopH broadly targets
most members of the TCR signaling complexes, or selec-
tively few members of the complex whose lack of phosphor-
ylation would lead to the hypophosphorylation of other
members of the TCR signaling complex and the inability of
inducing calcium flux and PI3K activity, we analyzed the ty-
rosine phosphorylation patterns of activated T cells exposed
to wild-type 
 
Y. pseudotuberculosis
 
 at lower MOIs. Initial ex-
periments were performed in Jurkat cells. T cell activation of
primary murine 5C.C7 T cells and the human Jurkat T cells
are similar in their sensitivity to 
 
Y. pseudotuberculosis
 
 infection
(unpublished data). However, the biochemistry of antigen
receptor signaling complexes is well characterized in Jurkat
cells and mutant Jurkat lines defective in the TCR signaling
pathway are available.
As shown in Fig. 3, even in activated Jurkat cells exposed
to 
 
Y. pseudotuberculosis
 
 at an MOI of only 1.5, the overall ty-
rosine phosphorylation in response to TCR stimulation was
reduced. The most substantial decrease was observed for
phosphorylated LAT and SLP-76 (Fig. 3, A, lanes 2 and 4,
and B). In contrast, Lck, Tyr394, CD3
 
 
 
, and ZAP-70,
which are phosphorylated earlier in the signaling cascade,
and SLP-76–associated phosphoprotein of 130 kD (SLAP-
130; an adaptor protein binding to SLP-76, also known as
Fyb, or ADAP) were not as affected. This trend continued in
activated Jurkat cells exposed at an MOI of 5. After exposure
at an MOI of 15, most TCR signaling proteins were uni-
formly hypophosphorylated, but Tyr394-phosphorylated Lck
was still clearly detectable. The efficient dephosphorylation
of TCR signaling proteins is consistent with the results that
Figure 3. Inhibition of tyrosine phosphorylation in Jurkat T cells ex-
posed to wild-type Y. pseudotuberculosis. Jurkat T cells were exposed to 
Y. pseudotuberculosis at MOIs of 1.5, 5, and 15 for 1 h or left unexposed 
( ). Total lysates of 4   105 resting ( ) or OKT3-activated ( ) T cells were 
analyzed by antiphosphotyrosine blotting (pTyr). Subsequently, blots were 
stripped and reprobed with antibodies reacting with phosphotyrosine-
394-Lck (Lck-pY394), YopH, and actin. Labeled proteins were identified by 
reprobing with the corresponding antibodies. A representative result of 
three independent experiments is shown. (B) Amounts of tyrosine phos-
phorylated proteins were quantified in three independent experiments 
using the NIH Image. Error bars represent standard deviation. (C) Kinase 
activity of Lck in E6.1 Jurkat T cells unexposed or exposed to wild-type 
Y. pseudotuberculosis at MOIs of 1.5, 5, 15, and 50 or to yopHC403A-HA 
(YopHC/A) at an MOI of 50 was measured by ELISA in three independent 
experiments. Lck-deficient J.CaM1 Jurkat cells were used as negative con-
trol. Error bars represent standard deviation. 
JEM VOL. 201, February 7, 2005
 
365
 
ARTICLE
 
calcium flux and PI3K activity of T cells are efficiently al-
tered by exposure to 
 
Y. pseudotuberculosis
 
 (Figs. 1 and 2). Re-
cently, it was demonstrated that YopH inhibits the activity
of recombinant Lck in vitro and that Tyr394-phosphory-
lated Lck is a target of YopH in in vitro immunoprecipita-
tions with relatively high amounts of YopH (24). This has
led to the hypothesis that YopH prevents T cell antigen re-
ceptor signaling by inhibiting Lck as the first step in the sig-
naling cascade. Therefore, we analyzed Lck activity in 
 
Yer-
sinia
 
-exposed T cells. As shown in Fig. 3 C, no difference in
the activity of Lck in T cells exposed to low MOIs of 
 
Yer-
sinia
 
 (MOIs 1.5 and 5) or unexposed cells was observed, in-
dicating that the hypophosphorylation of signaling molecules
at these MOIs does not result from a reduction of Lck activ-
ity. Only at higher MOIs (15 and 50), we did find an inhibi-
tion of Lck activity. The results indicate that although YopH
appears to have the ability to target multiple proteins in T
cells at higher MOIs, LAT and SLP-76 or molecules respon-
sible for their phosphorylation, but not Lck, are primary tar-
gets of YopH at a low bacteria to T cell ratio.
YopH dissociates from its substrates after dephosphoryla-
tion. Catalytically inactive forms of YopH that forms stable
complexes with its substrates (8) have been used as a substrate
trap to identify its catalytic targets (14, 15, 24–27). It is well
documented that signaling complexes in mammalian cells are
organized in modules. Preferential sequestration and localiza-
tion of molecules in the modules confer the specificity and
the selectivity of activation. Thus, to identify YopH’s targets
in infected cells, we constructed two 
 
Y. pseudotuberculosis
 
strains (designated as 
 
yopHC403A-HA
 
 and 
 
yopHD356A-HA
 
)
that can deliver a hemagglutinin (HA)-epitope tagged sub-
strate trap form of YopH (YopHC403A-HA or YopHD356A-
HA) into host cells through their type III secrectory pathway.
This was to ensure that the translocated substrate-trap YopH
would be similarly localized in T cells as wild-type YopH.
The YopHC403A substrate trap has previously been used ex-
tensively to identify YopH targets in macrophages and epi-
thelial cells (14, 15, 25–27). For some phosphatases though,
mutation of the conserved aspartate (D356 in YopH) has
been found to result in a more efficient substrate trap (28).
We performed identical experiments and found no difference
in any of the results. For simplicity, only the results obtained
using 
 
yopHC403A-HA
 
 are presented. A 
 
Y. pseudotuberculosis
 
strain that delivers YopH-HA (designated as 
 
yopH-HA
 
) was
also generated as a control.
Jurkat cells were exposed to wild-type, YopH-deficient
(
 
 
 
YopH), 
 
yopH-HA
 
, and 
 
yopHC403A-HA Y. pseudotuberculosis
 
,
followed by activation with the CD3
 
 
 
-specific antibody
OKT3. As shown in Fig. 4, wild-type– as well as 
 
yopH-HA
 
–
exposed Jurkat cells showed no observable phosphorylation in
response to TCR stimulation (lanes 8 and 10), indicating that the
HA-tag does not affect the activity of YopH. In contrast, expo-
sure to 
 
 
 
YopH or 
 
yopHC403A-HA Yersinia
 
 did not inhibit
TCR signaling even at an MOI of 50 (lanes 4 and 6). Compa-
rable amounts of YopH, YopH-HA, and YopHC403A-HA
were present in the exposed T cells (Fig. 4, YopH).
The level of SLP-76 phosphorylation before TCR stim-
ulation was much higher in Jurkat cells exposed to 
 
yopHC403A-
HA
 
 at an MOI of 50 (lane 5) than in unexposed or 
 
 
 
YopH-
exposed cells (lanes 1 and 3). Also LAT, SLAP-130, and
Vav, were also found to be slightly hyperphosphorylated be-
fore TCR stimulation and significantly hyperphosphorylated
after TCR activation. It has been observed previously that
binding of a phosphatase substrate-trap to its target protects it
from endogenous phosphatases, resulting in a relative in-
crease in the phosphorylated form of these molecules (28).
These results suggest that phosphorylated LAT, SLP-76,
SLAP-130, and Vav, rather than molecules responsible for
their phosphorylation, are direct targets of YopHC403A-
HA in T cells exposed at the MOI of 50.
Lck, CD3
 
 
 
, and ZAP-70 are phosphorylated earliest in
the TCR-mediated signaling pathway. This leads to the
phosphorylation of LAT and the recruitment of several pro-
teins, including phospholipase C-
 
 
 
1, PI3K, and Grb2-like
adaptor protein downstream of Shc (Gads). SLP-76 is consti-
tutively associated with Gads and, thus, is recruited to the
TCR signaling complex and subsequently phosphorylated.
Phosphorylated SLP-76 attracts more proteins, including
SLAP-130 and Vav, to the protein assembly, referred to as
the LAT/SLP-76 signalosome (19, 29, 30).
As shown in Fig. 5, a significant amount of phosphory-
lated SLP-76, and in addition phosphorylated LAT and
SLAP-130, the unphosphorylated Gads and two unidentified
Figure 4. Analysis of the effects of YopH variants on TCR-stimulated 
tyrosine phosphorylation. Immunoblot analysis of resting ( ) and OKT3-
activated ( ) Jurkat T cells that were either unexposed ( ) or exposed for 
1 h at an MOI of 50 of the following Y. pseudotuberculosis strains: WT, 
YopH-deficient ( H), yopHC403A-HA (yopHC/A-HA), and yopH-HA (yopH-
HA). Total lysates of 4   105 T cells were first probed with antiphosphoty-
rosine antibodies (pTyr). Subsequently, the blot was stripped and reprobed 
with anti-YopH and anti-actin antibodies. Labeled proteins were identified 
by reprobing with the corresponding antibodies. A representative result of 
three independent experiments is shown. 
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phosphorylated proteins of 
 
 
 
50-kD and 65-kD size (lane 2)
coprecipitated with YopHC403A-HA in lysates of activated
Jurkat cells exposed to 
 
yopHC403A-HA
 
 at an MOI of 2.
Phosphorylated Vav was present in the precipitate derived
from T cells exposed at an MOI of 50 (unpublished data).
Also a small amount of Lck was detected in YopHC403A
precipitates from cells exposed to an MOI of 50. The pre-
cipitated 50- and 65-kD protein are likely to be part of the
LAT/SLP-76 signalosome because phosphorylated proteins
of 50- and 65-kD size also coprecipitated with LAT or SLP-
76 from extracts of activated Jurkat cells (unpublished data).
Because the coupling of the integrin signaling pathway
with the TCR activation pathway is known to be defective in
Jurkat cells and 
 
Yersinia
 
 attachment was found to trigger the
integrin signaling cascade in macrophages and epithelial cells,
we assessed targets of YopHC403A-HA in 5C.C7 T cell
blasts. We did not find focal adhesion kinase (FAK), paxillin,
or p130
 
cas
 
, which are primary targets of YopH in macrophages
and epithelial cells (14, 15, 25, 26), nor did we find the closely
related PYK2 (to FAK) and p105
 
CasL
 
 (to p130
 
cas
 
), but again
found LAT, SLP-76, and SLAP-130 and two proteins of 50
and 65 kD to be targets (unpublished data).
To verify that binding of YopHC403A-HA to the co-
precipitating proteins occurred in the T cells and was not a
result of YopHC403A-HA binding to host proteins in the
lysate, we incubated Jurkat T cells with a mutant Yersinia
strain that is incapable of translocating YopH into eukaryotic
cells, an lcr mutant (31) expressing YopH-HA. The infection
did not affect TCR-stimulated tyrosine phosphorylation
(Fig. 6 A), and we were not able to precipitate YopH-HA
from lysates of the exposed T cells, even though the lcr
mutant synthesized similar amounts of the epitope-tagged
YopH compared with the wild-type strain (Fig. 6, B and C).
These results showed that, under the experimental condi-
tions we used for T cell lysis, there was no concomitant lysis
of Yersinia and that the precipitated YopH protein was that
which had been injected into T cells.
Although we did not detect CD3  or ZAP-70 in our co-
precipitates when substrate trap YopH was injected into T
cells by Yersinia, CD3  and ZAP-70 were found to copre-
cipitate with YopHC403A in in vitro immunoprecipitations
when the protein was added to lysates of activated Jurkat
cells in amounts similar to what is translocated by the bacte-
ria at an MOI of 2 (unpublished data). Thus, YopHC403A
appears to bind less specifically in vitro. Also when using
WT YopH for in vitro immunoprecipitations, we found
LAT, SLP-76, SLAP-130, ZAP-70, and CD3 , indicating
Figure 5. Substrate trap YopH associates with multiple components 
of the LAT/SLP-76 signalosome in activated Jurkat T cells. Detergent 
lysates of OKT3-activated Jurkat T cells exposed to yopHC403A-HA Yersinia 
at an MOI of 2 for 1 h, or left unexposed, were subjected to immunopre-
cipitation with affinity-purified anti-YopH antibodies ( -YopH) or protein 
G alone ( ). (A) Antiphosphotyrosine blot of 4   105 T cell equivalents of 
the lysates before (L) and after (dL) immunoprecipitation and the immu-
noprecipitated complexes (IP) from 3   107 T cell equivalents. A represen-
tative result of at least three independent experiments is shown. (B) Blots 
were stripped and reprobed with a panel of antibodies to identify the pre-
cipitated proteins. Anti–SLAP-130, SLP-76, LAT, and Gads antibodies 
bound to proteins coprecipated with YopHC403A-HA (lane 2). The phos-
phorylated proteins of 50-kD and 65-kD size (A, lane 2) could not be iden-
tified. The white line indicates that intervening lanes have been spliced 
out. (C) Blots were reprobed with anti–HA-tag antibodies (to detect 
YopHC403A-HA) and actin antibodies.
Figure 6. YopH precipitated from T cell lysates is YopH that had 
been injected. (A) Antiphosphotyrosine blot of total lysates of 4   105 
OKT3-activated Jurkat T cells exposed to yopH-HA or a YopH-HA–expressing 
lcr mutant strain (lcr yopH-HA) at an MOI of 50 for 1 h. (B) Anti-HA blot of 
the anti-YopH immunoprecipitated proteins from lysates of 4   106 Jurkat 
cells was exposed and activated as described in A. (C) Anti-HA blot of lysates 
of 4   105 T cells was exposed as in A, but lysed by boiling in SDS sample 
buffer, which also lyses the bacteria.JEM VOL. 201, February 7, 2005 367
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that binding to these proteins is not limited to substrate trap
YopH (unpublished data).
Because several phosphorylated proteins of the LAT/
SLP-76 signalosome were found to precipitate with the sub-
strate-trap YopH in exposed T cells, it was possible that the
substrate trap YopH bound directly to every coprecipitated
protein, or that it bound to one or a few of the proteins and
precipitated the entire complex. To distinguish between
these possibilities, we characterized YopH targets in Jurkat
cells that were either SLP-76 deficient (J14; reference 32) or
LAT deficient (J.CaM2; reference 33). In J14 cells, LAT and
the 65-kD protein still coprecipitated with YopHC403A-
HA (Fig. 7 A, lane 9). SLAP-130 and the 50-kD protein
were barely detectable. This indicates that their association
with YopHC403A-HA in wild-type T cells is mediated
largely via SLP-76. In activated J.CaM2 cells, the lack of
LAT expression resulted in a general reduction of phosphor-
ylation level. Phosphorylated SLP-76 could not be detected
in the T cell lysate. No phosphorylated proteins were found
to coprecipitated with YopHC403A-HA (lane 7) after expo-
sure to an MOI of 2. Because the signaling cascade from the
T cell receptor is interrupted in these Jurkat mutants, we
stimulated yopHC403A-HA–exposed Jurkat cells (MOI 2)
with per-vanadate to increase the phosphorylation of signal-
ing molecules (Fig. 7 B). The Lck-deficient Jurkat line
J.CaM1 (34) was also included in these experiments. In acti-
vated J.CaM1 cells, the overall phosphorylation level was
greatly reduced compared with wild-type Jurkat cells. How-
ever, SLP-76, LAT, the 65-kD protein, and SLAP-130 still
coprecipitated with YopHC403A, indicating that the pres-
ence of Lck is not required for the binding of those proteins
to YopHC403A. In the LAT-deficient Jurkat line, SLP-76,
SLAP-130, and the 50- and 65-kD proteins were detected,
indicating that the binding of YopHC403A to these proteins
is not dependent on LAT. In addition, we detected ZAP-70
coprecipitating with YopHC403A in these experiments,
suggesting that artificial hyperphosphorylation of signaling
molecules allows YopH to bind to additional proteins.
Targeting of additional proteins by YopH could also be
observed by in J.CaM2 cells exposed to yopHC403A-HA at
an MOI of 50 and activated through the TCR. Under these
conditions, phosphorylated SLAP-130 as well as phosphory-
lated CD3  and ZAP-70 coprecipitated with YopHC403A-
HA, indicating that a loss of YopH specificity occurs when it
is present at high concentration. This finding correlates with
the observation that at high MOIs, CD3  and ZAP-70 were
dephosphorylated by Y. pseudotuberculosis (Fig. 3), as were
most of the TCR signaling proteins. These results indicate
that, whereas YopH has a preference for LAT and SLP-76 in
T cells, in their absence, or at higher concentrations of
YopH, additional proteins will be targeted.
DISCUSSION
Suppression or evasion of host immune responses is necessary
for pathogenic bacteria to establish infection. In previous
work, we showed that Yersinia have the ability to directly
suppress T cell reactivity and that this inhibition is dependent
on the virulence factor YopH (7). In this paper, we showed
that the inhibitory effect of YopH is very potent as an average
of one bacterium per T cell is sufficient to inhibit or alter T
Figure 7. YopH substrate trap-associated tyrosine phosphorylated 
proteins in LAT- and SLP-76–deficient Jurkat cells. (A) Antiphospho-
tyrosine blot of anti-YopH immunoprecipitated proteins from total lysates 
of OKT3-activated Jurkat T cells (E6.1) and the E6.1-derived mutants J14 
(SLP-76 deficient) and J.CaM2 (LAT deficient), exposed to yopHC403A-HA 
Yersinia at an MOI of 2 for 1 h. Lysates of 4   105 T cells before (L) and 
after (dL) immunoprecipitation and the precipitated immunocomplexes 
(IP) of 3   107 T cell equivalents were analyzed. A representative result 
of three independent experiments is shown. Blots were reprobed with 
actin antibodies and anti–HA-tag antibodies (to detect YopHC403A-HA). 
(B) Tyrosine-phosphorylated proteins associated with YopHC403A in 
per-vanadate–stimulated E6.1, J14, J.CaM2, and J.CaM1 (Lck deficient) 
Jurkat cells were analyzed as in A. A representative result of three inde-
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cell responses. We traced the efficient inhibiting effect of
YopH to its primary targeting of the adaptor molecules LAT
and SLP-76 in the TCR signaling cascade. In addition, a 65-
kD protein that coprecipitated with YopHC403A in wild-
type and SLP-76–deficient Jurkat T cells also appears to be a
primary target of YopH. This protein is likely to be part of
the LAT/SLP-76 signalosome and it will be interesting to re-
veal its function. LAT and SLP-76 are essential for T cell ac-
tivation and function (32, 33, 35) and targeting of LAT and
SLP-76 alone by YopH can explain the YopH-dependent ef-
fects in T cell signaling we observed. This is the first time that
LAT and SLP-76 are found to be the targets of a pathogen
and underscores the importance of the adaptor proteins in the
T cell response in an infection.
Our results are different from those reported by Alonso et
al. (24), who found Lck, especially tyrosine 394 of Lck, to be
the main target of YopH. The discrepancies are most likely
due to differences in the amount of YopH used and the man-
ner of its delivery into the cells. We constructed Yersinia
strains that inject substrate trap YopH into cells to ensure that
the mutant YopH is delivered by the same route and in simi-
lar quantity as translocated WT-YopH. Alonso et al. ex-
pressed YopH in transiently transfected T cells, treated T cells
with membrane-permeable YopH, or added YopH to lysed
cells. Furthermore, to identify targets of YopH, Alsonso et al.
added  150 times as much substrate trap YopH to T cell ly-
sates as is translocated by Yersinia at an MOI of 2. Indeed, at
an MOI of 50, we also see Lck being targeted by YopH.
The ability to alter T cell signaling as seen in the sparking
phenotypes of calcium flux and PI3K activity is consistent
with our identification of LAT and SLP-76 as major targets
of YopH. The sparking pattern of calcium flux is similar to
the ones observed in T cells with a deletion of Itk, a Tec
family kinase that associates with phosphorylated SLP-76
(36), or a mutation in LAT. In the Itk-deficient T cells,
TCR stimulation results in a substantial reduction in IP3
generation and defects in IL-2 production. Jurkat cells ex-
pressing LAT Tyr132Phe or T cells from “knockin” mice
homozygous for LAT Tyr136Phe (Tyr136 in murine LAT is
equivalent to Tyr132 in human LAT) also are deficient in
their ability to respond to TCR stimulation (37, 38). Partial
dephosphorylation of LAT and SLP-76 might be conferred
by very limited quantities of injected YopH and, thus, could
profoundly alter TCR-mediated signaling and the subse-
quent responses in Yersinia infection. This suggests that, dur-
ing a Yersinia infection, a wide range of T cell–mediated
responses may be affected. In addition, abnormal T cell
signaling has been linked to the development of autoim-
mune diseases, particularly rheumatoid arthritis, in which the
aberrant T cell signaling has been linked to severely impaired
phosphorylation of LAT (39). One might speculate that the
ability of Y. pseudotuberculosis to disrupt or alter T cell signal-
ing could also play a role in triggering this disease.
When exposing T cells to Yersinia at low MOIs, wild-
type as well as substrate trap YopH injected into T cells
through the type III secretion system primarily targets LAT
and SLP-76, but not Lck, CD3 , or ZAP-70, even though
the latter three molecules are phosphorylated earlier during
T cell activation. The selectivity of YopH may in part result
from the amino acid sequences of the target proteins. In
vitro analysis has shown that the optimum peptide sequence
for YopH catalysis is D/E D/E pYxxP (40). The amino-ter-
minus of YopH that exhibits a substrate-binding domain that
binds substrates directly in a phosphotyrosine-dependent
manner (25) contributes to this selectivity. Both, SLP-76 and
LAT, but not CD3 , ZAP-70, and Lck, feature tyrosine
phosphorylation sites comprising the optimal motif for
YopH’s phosphatase activity. However, when T cell lysates
were incubated with an amount of YopHC403A similar to
the amount injected by Yersinia into T cells at an MOI of 2,
CD3  and ZAP-70 were found to bind to substrate trap
YopH, indicating that there may be additional unidentified
targeting mechanisms that contribute to YopH specificity.
An additional targeting mechanism might be provided by
the proline-rich region of YopH that shows the consensus
motif for binding to Src homology 3 domains (25, 41) and
that might confer binding in a phosphorylation-independent
manner. Studies in macrophages did not find this region of
YopH to be important for the targeting of YopH (25, 42).
However, Src homology 3 domains are present (e.g., in the
small adaptor Gads), but we did not find any evidence that
catalytically active YopH has the ability to bind to Gads (un-
published data).
The difference in the specificity of YopH when deliv-
ered into live cells compared with in vitro experiments sug-
gests that the accessibility of signaling complexes in live cells
plays an important role. Many signaling complexes in mam-
malian cells are organized into modules and preferential se-
questration and localization of these modules allows for spec-
ificity and selectivity of activation. Furthermore, cellular
compartmentalization and localization is important for the in
vivo substrate specificity of phosphatases that have a broad
substrate spectrum in vitro (43). Thus, delivery of YopH
through the type III secretory pathway likely determines the
interactions of YopH with the host cell signaling modules.
In addition, specificity of YopH is also influenced by its con-
centration. In T cells exposed to higher MOIs, YopH targets
additional proteins, including Lck. This indicates that, al-
though YopH shows broad targeting capabilities, it is very
specific at low bacteria to host cell ratios, a likely situation in
infections in vivo.
Despite the observation that the action of Yop effectors
shows no cell specificity among various adherent cells lines
(44), YopH is the only Yersinia effector protein affecting T
cells (7). The data presented here suggest that Yersinia may
have developed a sophisticated mechanism to target effector
proteins to special cellular compartments so that the effect of
the few virulence factors delivered by a few bacteria can be
maximized. This strategy may not be limited to Yersinia be-
cause type III secretion systems have been found in other
pathogenic microorganisms, such as Salmonella, Shigella, and
Chlamydia, that are also associated with reactive arthritis inJEM VOL. 201, February 7, 2005 369
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humans (45). It is likely that these bacteria secrete molecules
analogous to Yops that may alter host cell function and the
immune response to the benefit of the microbe. For exam-
ple, Salmonella translocates the effector protein, SptP, which
has domains corresponding to those found in the Yersinia
YopH and YopE (46).
In conclusion, we have identified a novel and efficient
mechanism by which bacteria alter T cell responsiveness.
These findings may have general applicability to the under-
standing of bacterial pathogenicity and the development of
immune responses during infection.
MATERIALS AND METHODS
Cell lines, Y. pseudotuberculosis strains, and growth conditions.
Wild-type Jurkat T cells E6.1 (47) and the mutant Jurkat T cell lines
J.CaM1 (Lck-deficient; reference 34), J.CaM2 (LAT-deficient; reference
33), and J14 (SLP-76 deficient; reference 32) were maintained in IMDM
medium (GIBCO BRL) containing 5% calf serum with iron and the stan-
dard supplements 5 mM L-glutamine, 50  M  -mercaptoethanol, and 50
 g/ml gentamycin at 37 C in 5% CO2. T cell blasts were derived from
5C.C7 TCR transgenic mice (specific for MCC/I-Ek; reference 22) by
stimulating freshly isolated lymph node cells with MCC peptide (88–103) in
supplemented RPMI 1640 medium containing 10% FBS. 25 U/ml IL-2
was added 24 h after stimulation. 5C.C7 T cell blasts expressing PH(AKT)-
YFP were generated by retroviral transfection as described by Huppa et al.
(21). T cell blasts were used on days 6 and 7 after initial stimulation. The B
cell lymphoma line CH27 was used as antigen-presenting cells and main-
tained in complete RPMI 1640.
Wild-type  Y. pseudotuberculosis YPIIIpIB1 (48), the YopH-deficient
( YopH) strain YPIIIp502 (49), and newly generated mutant strains were
grown in 2YT medium at 26 C and the appropriate antibiotics: 100  g/ml
ampicillin, and 32  g/ml chloramphenicol. For T cell infections, overnight
cultures were diluted to an OD578 of 0.1 into 2YT supplemented with 20
mM sodium oxalate and 20 mM magnesium chloride, grown for 2 h at
26 C, and shifted to 37 C for 2 h. Bacterial numbers were determined by
OD578   109 bacteria/ml.
Y. pseudotuberculosis strains that secrete HA-tagged YopH or HA-tagged
substrate trap YopH (designated as yopH-HA,  yopHC403A-HA, and
yopHD356A-HA, respectively), were generated as follows. The genes en-
coding YopH or YopHC403A were amplified including the promoter re-
gions from YPIIIpIB1 or the substrate trap YopHC403A-expressing strain
YPIIIpIB1C403A (9) and were inserted into pACYC184 (50). The HA-tag
was introduced at the 3 -end of yopH and yopHC403A. The resulting plas-
mids pyopH-HA and pyopHC403A-HA were introduced into YPIIIp502.
In addition, pyopH-HA was also introduced into the lcr mutant YPIIIpIB71
(31), yielding the strain lcr (pyopH-HA). pyopHD356A-HA was generated
by site-directed mutagenesis of pyopH-HA using Quikchange (Stratagene)
and introduced into YPIIIp502.
His-tagged YopHC403A (His-YopHC403A) as well as a glutathion
S-transferase (GST) fusion protein of YopHC403A (GST-YopHC403A) were
expressed in Escherichia coli. yopHC403A was inserted into pQE30 (QIAGEN)
to produce His-YopHC403A. GST-YopHC403A was encoded by a pGEX-
4T-1 (Amersham Biosciences) derivative containing yopHC403A.
Antibodies. A polyclonal antiserum to YopH was generated at Josman,
LLC by immunizing rabbits with purified His-YopHC403A. The crude an-
tiserum was affinity purified (51) using GST-YopHC403A fusion protein
bound to glutathione sepharose (Amersham Biosciences). Anti–human
CD3  (OKT3) was purified from hybridomas (American Type Culture
Collection). In addition, antibodies against the following proteins and resi-
dues were used in this study: antiphosphotyrosine (4G10), LAT, Lck, Gads,
ZAP-70, Vav, FAK (Upstate Biotechnology); CD3 , actin (Santa Cruz
Biotechnology, Inc.); SLP-76, SLAP-130, paxillin, p130cas, PYK2 (Trans-
duction Laboratories); phospho-Lck Tyr394 (detected by anti–phospho-Src
family [Tyr416] antibody; Cell Signaling), mouse CD3  (2C11)-biotin (BD
Biosciences); HA-tag (HA.11; Covance). Anti–mouse IgG horseradish per-
oxidase (HRP) linked whole antibody and anti–rabbit IgG HRP linked
F(ab )2 fragments were purchased from Amersham Biosciences.
T cell infection and activation. 106 cells/ml Jurkat T cells or 2   106
cells/ml 5C.C7 T cell blasts were exposed to specific Y. pseudotuberculosis at
a specified MOI for 1 h in prewarmed supplemented IMDM or RPMI
1640 without gentamycin in tissue culture plates at 37 C and 5% CO2. To
facilitate contact between the bacteria and the T cells, the plates were spun
for 3 min at 1,200 revolutions/min at the beginning of the infection. After
the exposure, the T cells were collected in 1.5-ml tubes by centrifugation
for 1.5 min (2 min for T cell blasts) at 1,600 revolutions/min (200 g) and
washed four times with prewarmed PBS (37 C) to remove most of the un-
attached Yersinia.
Jurkat T cells were activated at 4   107 cells/ml in PBS at 37 C by add-
ing OKT3 to a final concentration of 10  g/ml. For the activation of T cell
blasts, anti-CD3  2C11-biotin was preincubated with streptavidin and added
at a final concentration of 10  g/ml. For stimulation with per-vanadate (100
 M final concentration), ortho-vanadate was oxidized using H2O2, which
was subsequently removed using catalase. After incubation for 2 min (vana-
date 3 min), cells were spun down for 10 s at 4 C and lysed at 4   107 cells/
ml (Jurkat) or 108 cells/ml (T cell blasts) in ice-cold TTS (25 mM Tris, pH
8.0, 150 mM NaCl, 1% Triton X-100, 1 mM Na3VO4, 10 mM  -glycerol-
phosphate, 10 mM NaF, Complete protease inhibitors (Roche). Nuclei
were removed by centrifugation for 10 min at 13,000 revolutions/min
(16,000 g) at 4 C. Total lysates of 4   105 Jurkat cells or 2   106 T cell blasts
were resolved by SDS-PAGE. Phosphotyrosine proteins were detected by
immunoblot analysis using 4G10 antibody and the enhanced chemilumines-
cence system ECL (Amersham Biosciences). Blots were stripped according
to the protocol provided by Amersham Biosciences and subjected to reprob-
ing with appropriate antibodies. Results were quantified using the public do-
main NIH Image program (developed at the U.S. National Institutes of
Health and available at http://rsb.info.nih.gov/nih-image).
Immunoprecipitation of YopH-associated proteins. To identify Yop-
HC403A/YopHD356A targets in exposed T cells, 3   107 Jurkat T cells
were exposed to yopHC403A-HA or yopHD356A-HA at an MOI of 2, ac-
tivated, and lysed as described in the previous paragraph. Extracts were pre-
cleared using protein G agarose (Sigma-Aldrich) and subsequently incu-
bated for 2 h at 4 C with affinity purified anti-YopH antibodies or anti-HA
monoclonal antibodies (final concentration of 10  g/ml) and protein G
agarose. The agarose was collected by centrifugation for 3 min at 16,000 g at
4 C, washed three times with TTS buffer, and boiled with reducing SDS
sample buffer. The proteins were separated by SDS-PAGE and analyzed by
Western blot analysis. For in vitro immunoprecipitations, Jurkat cells were
activated and lysed, and YopHC403A, YopHD356A, or YopH were added
to the precleared lysate. YopH was preincubated in lysis buffer with 1 mM
vanadate for 15 min to inactivate it before adding it to the lysate. To match
the amount of purified YopH proteins added to the in vitro experiments
with the amount translocated by Yersinia, we compared the amounts of
YopH injected into Jurkat T cells with a titration curve of YopH. We
found that  20 ng of protein are translocated by Yersinia into 107 T cells
exposed at an MOI of 2.
Lck kinase assay. Jurkat T cells were exposed to Yersinia as described be-
fore, stimulated with OKT3, and lysed in kinase assay buffer KAB (25 mM
Hepes, pH 7.4, 150 mM KCl, 5 mM MnCl, 5 mM MgCl2, 1 mM DTT,
1% Triton X-100, 1 mM Na3VO4). Lysates were precleared and incubated
with 10  g/ml anti-Lck monoclonal antibody and protein G agarose. The
agarose was washed three times in KAB. Kinase activity was measured by
ELISA as follows. The cytoplasmic domain of CD3  ([Biotin][AHX]
GGQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQL
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coated Immulon 4 plates. Precipitated Lck was added for 30 min at 32 C
in KAB containing 20  M ATP. Phosphorylation of the CD3 -pep-
tides was quantified using antiphosphotyrosine antibody 4G10, anti–mouse
IgG HRP conjugate and the HRP substrate OPD (Sigma-Aldrich) in com-
parison to a standard curve of phosphorylated CD3 -peptide (0.05–
12.5 ng/ml). Lck-deficient Jurkat cells (J.CaM1) were used as negative
control.
Calcium flux and PI3K activity analysis. To analyze calcium flux by
flow cytometry, 106 T cell blasts were exposed to specified Y. pseudotubercu-
losis strains and concurrently loaded with 2  M indo-1, AM (Molecular
Probes) for 30 min. T cells were collected by centrifugation at 1,600 revo-
lutions/min (200 g) for 2 min in 1.5-ml tubes and washed twice with pre-
warmed antibiotic-free RPMI 1640 containing 25 mM Hepes, pH 7.4.
Indo-1 loaded T cells were activated by the addition of 2C11-biotin anti-
body (preincubated with streptavidin) to a final concentration of 10  g/ml.
Calcium flux was analyzed at 37 C on a modified FACStar (FACS facility,
Stanford University) by monitoring the ratio of 405/485 nm emission and
time. As a positive control, 1  M ionomycin (Sigma-Aldrich) was added to
the T cells at the end of the measurement.
Calcium flux and the PI3K activity of T cells responding to antigenic
stimulation were analyzed by single cell video microscopy using a Zeiss/
Universal Imaging three-dimensional time-lapse system as described previ-
ously (21). 2   105 T cell blasts expressing the PH(AKT)-YFP were ex-
posed to Yersinia and loaded with 1  M fura-2, AM (Molecular Probes).
After washing, the cells were resuspended in 200  l prewarmed antibiotic-
free RPMI 1640 supplemented with 25 mM Hepes, pH 7.4, and seeded
into an eight-well glass-bottom chamber slide (Labtek/Nunc). 105 CH27
cells, preloaded with 1  M MCC peptide for 1 h, were added to the T
cells. Images were taken every 15 or 30 s for 15 min. At each time point,
images of the two-dimensional differential interference contrast, the fura-2
fluorescence images (340/380 nm) and a z stack of YFP were recorded.
Metamorph (Universal Imaging Corp.) was used for microscope control,
data acquisition, and image analysis.
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